Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Non Operating Income: 2015-2025

Historic Non Operating Income for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to $2.5 million.

  • Wave Life Sciences' Non Operating Income rose 17.14% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 46.86%. This contributed to the annual value of $13.4 million for FY2024, which is 36.60% up from last year.
  • Latest data reveals that Wave Life Sciences reported Non Operating Income of $2.5 million as of Q3 2025, which was up 9.21% from $2.3 million recorded in Q2 2025.
  • Wave Life Sciences' 5-year Non Operating Income high stood at $6.3 million for Q4 2024, and its period low was -$701,000 during Q3 2022.
  • Moreover, its 3-year median value for Non Operating Income was $2.4 million (2023), whereas its average is $2.8 million.
  • As far as peak fluctuations go, Wave Life Sciences' Non Operating Income plummeted by 150.91% in 2022, and later spiked by 928.57% in 2023.
  • Quarterly analysis of 5 years shows Wave Life Sciences' Non Operating Income stood at $1.1 million in 2021, then tumbled by 52.27% to $535,000 in 2022, then soared by 353.46% to $2.4 million in 2023, then skyrocketed by 159.11% to $6.3 million in 2024, then rose by 17.14% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $2.3 million for Q2 2025, and $2.9 million during Q1 2025.